Seelen MAJ - Search Results

1

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG. Kamburova EG, et al. Among authors: seelen maj. Am J Transplant. 2019 Dec;19(12):3335-3344. doi: 10.1111/ajt.15493. Epub 2019 Jul 3. Am J Transplant. 2019. PMID: 31194283 Free PMC article.

2

Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.

Munster JM, van der Bij W, Breukink MB, van der Steege G, Zuurman MW, Hepkema BG, Verschuuren EA, van Son WJ, Seelen MA. Munster JM, et al. Transplantation. 2008 Dec 27;86(12):1857-63. doi: 10.1097/TP.0b013e31819064b8. Transplantation. 2008. PMID: 19104434

3

Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation.

van Ree RM, de Vries AP, Oterdoom LH, Seelen MA, Gansevoort RT, Schouten JP, Struck J, Navis G, Gans RO, van der Heide JJ, van Son WJ, Bakker SJ. van Ree RM, et al. Transplantation. 2009 Jul 27;88(2):279-87. doi: 10.1097/TP.0b013e3181ac9ea0. Transplantation. 2009. PMID: 19623026

4

Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury.

Damman J, Daha MR, van Son WJ, Leuvenink HG, Ploeg RJ, Seelen MA. Damman J, et al. Am J Transplant. 2011 Apr;11(4):660-9. doi: 10.1111/j.1600-6143.2011.03475.x. Am J Transplant. 2011. PMID: 21446970 Free article. Review.

5

Uromodulin in renal transplant recipients: elevated urinary levels and bimodal association with graft failure.

Reznichenko A, van Dijk MC, van der Heide JH, Bakker SJ, Seelen M, Navis G. Reznichenko A, et al. Am J Nephrol. 2011;34(5):445-51. doi: 10.1159/000332231. Epub 2011 Sep 29. Am J Nephrol. 2011. PMID: 21968132

6

Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.

Damman J, Kok JL, Snieder H, Leuvenink HG, van Goor H, Hillebrands JL, van Dijk MC, Hepkema BG, Reznichenko A, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA. Damman J, et al. Mol Immunol. 2012 Feb;50(1-2):1-8. doi: 10.1016/j.molimm.2011.11.009. Epub 2011 Dec 15. Mol Immunol. 2012. PMID: 22173059

7

Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys.

Damman J, Daha MR, Leuvenink HG, van Goor H, Hillebrands JL, Dijk MC, Hepkema BG, Snieder H, Born Jv, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Seelen MA. Damman J, et al. Am J Transplant. 2012 Mar;12(3):660-8. doi: 10.1111/j.1600-6143.2011.03880.x. Epub 2011 Dec 17. Am J Transplant. 2012. PMID: 22176838 Free article.

8

CCR5Δ32 genotype leads to a Th2 type directed immune response in ESRD patients.

Muntinghe FL, Abdulahad WH, Huitema MG, Damman J, Seelen MA, Lems SP, Hepkema BG, Navis G, Westra J. Muntinghe FL, et al. PLoS One. 2012;7(2):e31257. doi: 10.1371/journal.pone.0031257. Epub 2012 Feb 13. PLoS One. 2012. PMID: 22348061 Free PMC article.

9

CUBN as a novel locus for end-stage renal disease: insights from renal transplantation.

Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group. Reznichenko A, et al. PLoS One. 2012;7(5):e36512. doi: 10.1371/journal.pone.0036512. Epub 2012 May 4. PLoS One. 2012. PMID: 22574174 Free PMC article.

10

UMOD as a susceptibility gene for end-stage renal disease.

Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group. Reznichenko A, et al. BMC Med Genet. 2012 Sep 5;13:78. doi: 10.1186/1471-2350-13-78. BMC Med Genet. 2012. PMID: 22947327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page